Evidence map›Paper›PMID 41808235›Full record

ArticlePilot and feasibility studies2026

How to optimise the use of innovative invasive devices: considerations for feasibility studies.

Emily Hotton, Julia Wade, Daisy Elliott, Erik Lenguerrand, Joanna Crofts, Natalie Blencowe

Abstract read
In one paragraph

Article in Pilot and feasibility studies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emily HottonWomen and Children's Research Centre, Southmead Hospital, North Bristol NHS Trust, Bristol, UK. Emily.hotton@nhs.net.ORCID http://orcid.org/0000-0002-8570-9136
Julia WadeNIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Daisy ElliottNIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Erik LenguerrandTranslational Health Sciences, University of Bristol, Southmead Hospital, Bristol, UK.
Joanna CroftsWomen and Children's Research Centre, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
Natalie BlencoweNIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.

Funding

Gates Foundation INV-010180
6 · The paper itself

Abstract

Innovation in medical devices is essential for advancing patient care but has been undermined by inadequate evaluation and regulation. The UK vaginal mesh scandal exposed systemic flaws in medical device evaluation, where insufficient pre-market testing and ineffective post-market surveillance caused harm to countless women. Unlike pharmaceutical products, medical devices often enter clinical practice without robust evidence or long-term safety data. However, evaluation of devices can present methodological challenges, particularly when they are used during invasive procedures, given their multifaceted nature and contextual variables. Using the ASSIST study and the OdonAssist™ inflatable device for assisted vaginal birth as a case study, we wish to highlight these challenges and present a model for conducting feasibility studies of complex interventions. Early feasibility studies of the OdonAssist device demonstrated that although women accepted the innovation, the success rate of assisted vaginal birth was lower than anticipated. An embedded qualitative evaluation provided critical insights, revealing key factors influencing device use, design, and operator technique. The use of qualitative case study methodology allowed for systematic observation, stakeholder feedback, and iterative device refinement. For example, issues such as accidental activation of the deflation button were identified, leading to real-time design modifications in conjunction with industry partners. Stakeholder engagement-including patients, clinicians (doctors and midwives), ethics committees, and industry partners-was integral to optimising study design, device functionality, and training programmes. This collaborative, data-driven approach expedited the identification of modifications to device use, necessitating design changes and thereby ensuring device safety and usability. The evaluation of innovative devices like the OdonAssist requires a holistic approach that incorporates qualitative methodologies, stakeholder collaboration, and iterative feedback. Embedding case study research within feasibility trials ensures rapid identification of challenges, supports timely modifications, and fosters safer device implementation. Future research should explore video-recorded observations and enhanced patient feedback to refine device technique and training further.

Indexed as

Assisted vaginal birthFeasibilityIntrapartum researchMedical deviceMethodologyOdonAssistSafety

Identifiers

PMID41808235
PMCPMC13085334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.